TWYNSTA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Twynsta, and what generic alternatives are available?
Twynsta is a drug marketed by Boehringer Ingelheim and is included in one NDA.
The generic ingredient in TWYNSTA is amlodipine besylate; telmisartan. There are fifty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amlodipine besylate; telmisartan profile page.
Summary for TWYNSTA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Clinical Trials: | 7 |
Patent Applications: | 2 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TWYNSTA |
What excipients (inactive ingredients) are in TWYNSTA? | TWYNSTA excipients list |
DailyMed Link: | TWYNSTA at DailyMed |
Recent Clinical Trials for TWYNSTA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hanlim Pharm. Co., Ltd. | Phase 1 |
Addpharma Inc. | Phase 3 |
Research Institute for Complex Problems of Cardiovascular Diseases, Russia | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TWYNSTA
US Patents and Regulatory Information for TWYNSTA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-001 | Oct 16, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-004 | Oct 16, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-003 | Oct 16, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-002 | Oct 16, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TWYNSTA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-002 | Oct 16, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-004 | Oct 16, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-001 | Oct 16, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Boehringer Ingelheim | TWYNSTA | amlodipine besylate; telmisartan | TABLET;ORAL | 022401-003 | Oct 16, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TWYNSTA
See the table below for patents covering TWYNSTA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 660209 | ⤷ Try a Trial | |
Yugoslavia | 48849 | ⤷ Try a Trial | |
Singapore | 50481 | Benzimidazoles pharmaceutical compositions containing these compounds and processes for preparing them | ⤷ Try a Trial |
Hungary | 217816 | Eljárás benzimidazolszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására (PROCESS FOR PRODUCING BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TWYNSTA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0502314 | CA 2011 00008 | Denmark | ⤷ Try a Trial | |
0678503 | C300499 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE OMVATTEND ALISKIREN OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110114 |
0443983 | C300445 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: VALSARTAN, AMLODIPINE EN HYDROCHLOORTHIAZIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/09/569/001-060 20091016 |
0503785 | C300375 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE VAN OLMESARTAN MEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN AMLODIPINEBESILAAT; REGISTRATION NO/DATE: RVG100984, RVG100986-87, RVG100989-91, RVG100993-95 20080819 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |